Added to YB: 2024-03-13
Pitch date: 2024-03-13
GRFS [bullish]
Grifols, S.A.
+21.37%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.
Market Cap
EUR 5.4B
Pitch Price
EUR 7.83
Price Target
N/A
Dividend
3.45%
EV/EBITDA
9.52
P/E
14.27
EV/Sales
2.25
Sector
Biotechnology
Category
N/A
Show full summary:
GRIFOLS S A GRFS
A summary for this pitch has not been created yet.
Read full article (0 min)